Absci Unveils Preclinical Data for AI-Designed ABS-201, Targeting a Novel Hormonal Pathway for Hair Loss Treatment
Absci Corporation (NASDAQ:ABSI) is one of the best biotech penny stocks to buy according to analysts.
Absci Corp (ABSI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 12,162,773 | $36,974,831 | +22% | 0.22% |
| 2. | Redmile Group Jeremy Green | 8,253,316 | $25,090,081 | 2.44% | |
| 3. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,770,047 | $5,380,943 | -41% | 0.03% |
| 4. | Royce & Associates Chuck Royce | 1,261,433 | $3,834,756 | -17% | 0.04% |
| 5. | Casdin Capital Eli Casdin | 973,260 | $2,958,710 | 0.25% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.72 | 40,000 | $148,800.00 | 63,320 | 2025-12-05 | Filing | |
| $2.66 | 95,785 | $254,788.10 | 113,960 | 2025-09-22 | Filing | |
| $2.70 | 10,000 | $27,000.00 | 180,428 | 2025-09-22 | Filing | |
| $3.04 | 50,000 | $152,000.00 | 327,264 | 2025-07-28 | Filing | |
| $4.50 | 222,222 | $999,999.00 | 8,253,316 | 2024-03-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.98 | 19,859 | $98,891.86 | 384,751 | 2024-06-13 | Filing | |
| $4.40 | 3,100,000 | $13,640,000.00 | 11,279,522 | 2024-05-22 | Filing | |
| $1.44 | 40,439 | $58,248.34 | 14,379,522 | 2023-11-28 | Filing | |
| $1.40 | 12,959 | $18,165.93 | 14,379,522 | 2023-11-27 | Filing | |
| $1.42 | 10,779 | $15,326.66 | 14,379,522 | 2023-11-24 | Filing |
Institutional Investors' Holdings
News See All
Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial
Absci Corporation (NASDAQ:ABSI) announced on December 4, 2025, that the first healthy volunteers had been dosed in the Phase 1/2a HEADLINE clinical trial investigating ABS-201, an experimental anti-prolactin...
10 Best Biotech Penny Stocks to Buy According to Analysts
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
12 Best Genomics Stocks to Invest In
Companies that study DNA to improve people's lives are known as genomics stocks.
Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential
Absci Corporation (NASDAQ:ABSI) is among the Best Get Rich Fast Stocks to Buy Right Now.
13 Best Get Rich Fast Stocks to Buy Right Now
In today's fast-paced world, everyone is prioritising investments that have both high and relatively quick returns.
Absci Corporation (NASDAQ:ABSI)’s ABS‑201 Shows Promise in Hair Loss Treatment, Analysts See Upside
Absci Corporation (NASDAQ:ABSI) is one of the best multibagger penny stocks to buy right now.
14 Best Multibagger Penny Stocks to Buy Right Now
The Russell 2000 Index has hit fresh highs heading into 2026, signaling renewed interest in small companies.
Absci Corporation (NASDAQ:ABSI) Q3 2025 Earnings Call Transcript
Operator: Thank you for standing by. My name is Rochelle, and I will be your operator today. At this time, I would like to welcome everyone to the Absci Corporation Q3 2025 business update.
Absci Corporation (ABSI) Secures $64M Financing to Drive AI Drug Discovery Through 2028
Absci Corporation (NASDAQ:ABSI), founded in 2018 and headquartered in Seattle, is pioneering the integration of deep learning with high-throughput lab automation to design and optimize biologics at scale...
Hedge Fund Resource Center Billionaire Hedge Funds
